资讯

Could This Eli Lilly Oral Pill Be Key To Significant Weight Loss?

Eli Lilly and Co (NYSE:LLY) on Tuesday shared detailed results from the Phase 3 ATTAIN-1 trial, evaluating the safety and ...

Skkynet Reports Third Quarter 2025 Results

A Key Highlight is a 475% Increase in Subscription Revenue MISSISSAUGA, ONTARIO - September 17, 2025 (NEWMEDIAWIRE) - Skkynet ...
Investing.com Philippines

Eli Lilly stock rises as oral diabetes drug outperforms Novo Nordisk rival

Investing.com -- Eli Lilly and Company (NYSE:LLY) stock rose 1% after the company announced its experimental oral GLP-1 drug orforglipron demonstrated superior results compared to Novo Nordisk’s oral ...